- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Bronchiolitis Guidelines Tied to Fewer X-rays, Same Outcomes
Using bronchiolitis clinical practice guidelines (CPGs) was linked to reduced use of chest X-rays (CXRs), bronchodilators, steroids, and length of stay (LOS) in hospitalized children without affecting 7-day all-cause readmissions.
Pediatrics
Using bronchiolitis clinical practice guidelines (CPGs) was linked to reduced use of chest X-rays (CXRs), bronchodilators, steroids, and length of stay (LOS) in hospitalized children without affecting 7-day all-cause readmissions, according to a study published online February 17 in .
"Provider-dependent practice variation in children hospitalized with bronchiolitis is not uncommon," write Vineeta Mittal, MD, from the Department of Pediatrics, Children's Medical Center, and the University of Texas Southwestern Medical Center, Dallas, and colleagues. "[CPGs] can streamline practice and reduce utilization however, CPG implementation is complex."
A multidisciplinary team developed CPGs for bronchiolitis management in children younger than 2 years, excluding those with comorbid conditions, intensive care unit admissions, and outside hospital transfers.
Read the full story here: http://bit.ly/O3OSkh
Source: Medscape
Understanding the Unmet Need for Therapies to Treat Rare Bile Duct Cancer
May 24th 2022On this episode of Managed Care Cast, we bring you an excerpt of an interview with a co-chair of the 2022 Cholangiocarcinoma Foundation (CCF) annual conference, held earlier this year, about the significant unmet therapy needs facing most patients with this rare cancer.
Listen
Bimekizumab-bkzx, the Newest Psoriasis Treatment, Is Now Available
November 30th 2023Bimekizumab-bkzx (Bimzelx) is the first dual interleukin 17A (IL-17A) and interleukin 17F (IL-17F) inhibitor to treat moderate-to-severe plaque psoriasis. It launches with a list price of $7200 per syringe.
Read More
Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma
November 30th 2023A real-world study suggests high-dose chemotherapy followed by autologous stem cell transplantation (ASCT) is feasible for appropriately selected elderly patients, with similar results seen in older and younger patients.
Read More
